Cardiothoracic and Vascular Surgeons

What Cardiothoracic and Vascular Surgeons does

Cardiothoracic and Vascular Surgeons, P.A. (CTVS) is a privately held, physician-owned surgical group headquartered in Austin, Texas, founded in 1958. With 12 board-certified cardiothoracic surgeons plus vascular surgeons and physician extenders (PAs/NPs), and a total headcount of 51–100, it is the largest cardiothoracic surgery group in Central Texas. The practice specializes in cardiac surgery (CABG, valve repair/replacement, heart transplantation, TAVR, da Vinci robotic surgery, arrhythmia surgery, ECMO, VAD), thoracic surgery (VATS, thoracic aortic aneurysm repair), and vascular surgery (PAD treatment, EVAR, TCAR, carotid surgery, dialysis access, limb preservation). CTVS surgeons hold operating privileges at all Central Texas area hospitals and operate outpatient clinics in Austin, Kyle (Hays County), and Georgetown (Williamson County).

CTVS generates revenue primarily through professional surgical and medical services billed to most major insurance carriers via insurance claims, with a secondary revenue stream from sponsored clinical research participation (medical device and academic-sponsored trials including TREO, TAMBE, AccuCinch, APOLLO, SUMMIT, PERIGON, and TRILUMINATE). Patient acquisition is driven by physician referrals (with downloadable referral forms and a dedicated marketing contact), community and patient education (website, blog, YouTube, Facebook, Twitter), and brand reputation from 65 years of "firsts" in the region. Service delivery spans hospital-based surgical procedures and clinic-based outpatient consultations and minimally invasive procedures, the latter supported by an office-based Vascular Intervention Suite at the Georgetown location. Notable patient milestones include the first heart transplant in Central Texas (1986) and over 300 heart transplants performed cumulatively.

Name

Cardiothoracic and Vascular Surgeons

Legal name

Cardiothoracic and Vascular Surgeons, P.A.

Website

https://ctvstexas.com

Company type

Private

Founded year

1958

Operating status

Operating

Headcount range

101–250 employees

Short description

CTVS is a physician-owned private cardiothoracic and vascular surgery practice in Austin, Texas, founded in 1958, with 12 board-certified surgeons serving Central Texas patients across hospital-based and clinic-based care.

Ownership category

akta.pro rank

Product category

Cardiothoracic and Vascular Surgical Services

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Interventional Cardiology (PCI/Structural Heart) (HLAKABAB)

akta.pro secondary industry

Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK)

Keywords

• Cardiothoracic surgery
• Vascular surgery
• Heart transplantation
• Amputation prevention
• Minimally invasive surgery

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Surgical and Medical Services: CTVS generates revenue through providing surgical procedures and medical consultations. The practice accepts most major insurance carriers and submits claims on behalf of patients. Services include cardiothoracic surgery, vascular surgery, heart transplantation, and various interventional procedures.
2. Clinical Research: CTVS participates in clinical research studies sponsored by medical device companies and research institutions, which may include compensation for study participation and procedures.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

CTVS is a private physician-owned medical practice providing comprehensive cardiothoracic and vascular surgical care in Central Texas, including open and minimally invasive cardiac surgery (CABG, valve repair/replacement, heart transplantation, TAVR, robotic-assisted procedures), thoracic surgery (VATS, lung surgery, thoracic aortic aneurysm repair), vascular surgery (PAD treatment, AAA repair, EVAR, carotid/TCAR, dialysis access, venous disease), and a dedicated limb preservation and amputation prevention program.

Product overview

Cardiothoracic and Vascular Surgeons (CTVS) is a medical practice offering comprehensive cardiothoracic and vascular surgical care through multiple specialized services. The practice operates as a unified suite of surgical services including Cardiac Surgery Services (with sub-services like CABG, TAVR, heart transplantation, valve repair/replacement, da Vinci robotic surgery, and arrhythmia surgery), Vascular Surgery Services (including PAD treatment, AAA repair, endovascular procedures, and limb preservation), and specialized programs for amputation prevention and wound care. CTVS also provides a Patient Portal for secure patient communication and participates in Clinical Research Trials for advanced treatments. With 12 board-certified cardiothoracic surgeons, CTVS is the largest cardiothoracic and vascular surgery group in Central Texas, having pioneered numerous surgical procedures since 1961.

Differentiator

Problem solved

Functional benefit

Products and services

• Cardiac Surgery Services Comprehensive cardiac surgery services for adult patients with coronary artery disease, valve disease, arrhythmias, aortic disease, and end-stage heart failure.
• Coronary Artery Bypass Graft (CABG) Surgical procedure to improve blood flow to the heart by bypassing blocked coronary arteries.
• Transcatheter Aortic Valve Replacement (TAVR) Minimally invasive procedure to replace a narrowed heart valve without open heart surgery.
• da Vinci Robotic Surgery Robotic-assisted minimally invasive surgery for cardiothoracic procedures using the da Vinci Surgical System, providing 3D magnified vision and wristed instruments for enhanced precision.
• Heart Transplantation Complete heart transplant services for patients with end-stage heart failure.
• Minimally Invasive Cardiac Surgery (MICS) Minimally invasive small-incision cardiac procedures, including robotic-assisted surgery for valve repair and replacement.
• Ross Procedure Specialized valve replacement surgery using the patient's own pulmonary valve to replace a damaged aortic valve.
• Valve Repair and Replacement Surgical treatment for heart valve diseases including repair and replacement of mitral, aortic, and tricuspid valves.
• Arrhythmia Surgery Surgical treatments for heart rhythm disorders including cardioversion, pacemaker implantation, ICD placement, Maze procedure, and Convergent procedure.
• Extracorporeal Membrane Oxygenation (ECMO) Advanced life support for patients with severe heart and lung failure.
• Ventricular Assist Device (VAD) Mechanical circulatory support devices that help pump blood for patients with heart failure.
• Thoracic Aortic Aneurysm Repair Surgical repair of aneurysms in the thoracic aorta, including endograft procedures.
• Transmyocardial Revascularization (TMR) Surgical procedure to improve blood flow to the heart muscle for patients with severe angina.
• Vascular Surgery Services Comprehensive vascular surgery including treatment of peripheral artery disease, aneurysms, and circulatory disorders.
• Abdominal Aortic Aneurysm Repair (AAA / EVAR) Surgical and endovascular treatment of abdominal aortic aneurysms using stent grafts inserted through small incisions.
• Peripheral Artery Disease (PAD) Treatment Comprehensive treatment for PAD including medical therapy, minimally invasive procedures, and surgical revascularization.
• Carotid Disease Management and Surgery (including TCAR) Treatment for carotid artery disease including carotid endarterectomy and TCAR procedures for stroke prevention.
• Dialysis Access Surgical creation and maintenance of vascular access for dialysis patients.
• Complex Venous Disease Treatment Treatment of deep vein thrombosis, varicose veins, and other venous conditions.
• Vascular Intervention Suite (VIS) State-of-the-art office-based facility for performing minimally invasive vascular procedures under moderate sedation.
• Vascular Lab Screening Services Diagnostic testing for vascular conditions including blood flow measurements and artery/vein function assessment.
• Amputation Prevention & Limb Preservation Program Advanced treatment program to prevent limb amputations through early intervention, improved blood flow restoration, and wound healing.
• Diabetic Foot & Leg Ulcer Treatment Comprehensive treatment for diabetic foot and leg ulcers to prevent amputation and promote wound healing.
• Clinical Research Trials Participation in sponsored clinical research trials providing access to emerging cardiovascular and endovascular technologies and treatments.

Named customers6 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Nine partnerships are on record, tiered minor.

• HeartGiftminorOthersCTVS participates in community involvement through not-for-profit organizations like HeartGift, which provides surgical care for children with heart conditions.
• VOOM FoundationminorOthersDr. Jeffrey McNeil is involved with the VOOM Foundation, helping develop a cardiac surgery program in Nigeria through international medical mission work.
• Terumo AorticminorStrategic or Co-development PartnerSponsor of TREO Post-Approval Study of the TREO Abdominal Stent-Graft System in patients with infrarenal abdominal aortic and aorto-iliac aneurysms.
• W.L. Gore & AssociatesminorStrategic or Co-development PartnerSponsor of TAMBE Early Feasibility Assessment of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis for treatment of type IV thoracoabdominal aortic aneurysms.
• Ancora Heart, Inc.minorStrategic or Co-development PartnerSponsor of AccuCinch Early Feasibility Study of the AccuCinch Ventricular Repair System in patients with prior mitral valve intervention.
• MedtronicminorStrategic or Co-development PartnerSponsor of APOLLO Trial for Transcatheter Mitral Valve Replacement with the Medtronic Intrepid TMVR System and PERIGON trial for pericardial surgical aortic valve replacement.
• Abbott Medical DevicesminorStrategic or Co-development PartnerSponsor of SUMMIT Clinical Trial for the Tendyne Mitral Valve System and TRILUMINATE trial for the TriClip Tricuspid Valve Repair System.
• University of Texas Southwestern Medical CenterminorStrategic or Co-development PartnerSponsor of STABLE-MATES study comparing sublobar resection versus stereotactic ablative radiotherapy for lung cancer.
• National Cancer Institute (NCI)minorStrategic or Co-development PartnerSponsor of ALCHEMIST trial for genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Others

• Abbott Cardiovascular: Global medical device company sponsoring CTVS's participation in the SUMMIT (Tendyne) and TRILUMINATE (TriClip) trials. An enabling ecosystem participant whose structural heart and vascular product roadmap directly shapes CTVS's clinical offering.
• Medtronic: Global medical device company and a key CTVS clinical trial sponsor (APOLLO TMVR, PERIGON surgical aortic valve). Comparable as a strategic/ecosystem participant: the device innovation that drives CTVS's structural heart and endovascular program flows from companies like Medtronic.

Emerging players

• US Heart & Vascular: PE-backed (KKR-sponsored) national platform of independent cardiology and vascular practices. Represents the most active new competitive/consolidation threat to independent surgeon groups like CTVS, with capital and infrastructure advantages.

Broad incumbents

• Sanger Heart & Vascular Institute (Atrium Health): Hospital-employed cardiovascular specialty service line within Atrium Health in the Carolinas, offering a comparable comprehensive cardiac and vascular surgery portfolio (CABG, valve, TAVR, vascular, transplant) but operating as a system-owned program rather than an independent group.
• Cleveland Clinic Heart, Vascular & Thoracic Institute: Top-ranked academic cardiovascular specialty service line within Cleveland Clinic, providing the full spectrum of cardiac, thoracic, and vascular surgery. Comparable in clinical scope and quality reputation but at a national-scale academic institution rather than a regional private group.
• Baylor Scott & White Health (Cardiovascular service line): Large Texas-based integrated health system with a comprehensive cardiovascular surgery service line (CABG, valve, TAVR, vascular, heart transplant). Comparable in clinical scope but operates at a multi-state, multi-hospital system level rather than as an independent group.
• Texas Heart Institute: Premier independent cardiovascular research and treatment center in Houston, Texas. Overlaps in core surgical capabilities (heart transplant, valve, complex cardiac) but operates as a nationally branded academic/research institution rather than a regional private practice.
• HCA Heart Hospital of Austin: HCA-owned specialty cardiac hospital where many CTVS surgeons operate. Comparable as a delivery site for the same surgical services but functions as a hospital facility, not an independent physician group, and is a key partner/dependency for CTVS.

Direct peers

• Cardiac Surgery Associates: Independent private cardiothoracic and vascular surgery group practice with multiple offices across the Southeast U.S. Highly comparable in business model (private physician-owned, multi-surgeon, insurance-billed, hospital-privileged) and case mix (CABG, valve, thoracic, vascular).
• Cardiothoracic and Vascular Surgery Associates (CTVSA): Independent private practice group of cardiothoracic and vascular surgeons in the Midwest, with the same name root and similar practice structure — multi-surgeon group delivering cardiac, thoracic, and vascular surgical care on a referral-driven, insurance-billed model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/CTVSAustin
• YouTubeyoutube.com/channel/UC7fdLBKo7_eGxNH_KQJR-rg
• Facebookfacebook.com/Cardiothoracic-and-Vascular-Surgeons-134143750845

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cardiothoracic and Vascular Surgeons